|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.01 USD | +0.48% |
|
-.--% | +2.04% |
| 30/06 | Hologic Recalls BioZorb Implantable Markers, FDA Says | MT |
| 26/05 | Hologic and Biotheranostics Present New Data on Breast Cancer Index Test At Asco 2026 | CI |
| Market Cap | 1.7TCr 1.48TCr 1.36TCr 1.27TCr 2.41TCr 1,61500Cr 2.45TCr 16TCr 6.35TCr 79TCr 6.37TCr 6.23TCr 2,73000Cr | P/E 2024 |
24.3x | P/E 2025 | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 1.74TCr 1.52TCr 1.4TCr 1.3TCr 2.47TCr 1,65600Cr 2.51TCr 17TCr 6.51TCr 81TCr 6.53TCr 6.39TCr 2,79800Cr | EV / Sales 2024 |
4.74x | EV / Sales 2025 | 3.75x |
| Free-Float |
73.08% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Hologic, Inc.
| 1 day | +0.48% | ||
| 3 months | +0.54% | ||
| 6 months | +2.04% | ||
| Current year | +2.04% |
| Current year | 74.49 |  | 76.07 |
| 1 year | 63.19 | | 76.07 |
| 3 years | 51.9 | | 84.67 |
| 5 years | 51.9 | | 87.88 |
| 10 years | 26.49 | | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 63 | 07/04/2026 |
Brian Montgomery
DFI | Director of Finance/CFO | - | 16/04/2026 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Joe Almeida
BRD | Director/Board Member | 63 | 07/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/04 | Issuer sale | President, Breast & Skeletal | 59,146 | 0.0265% | ||
| 07/04 | Issuer sale | Director | 10,103 | 0.0045% | ||
| 07/04 | Issuer sale | Director | 1,03,367 | 0.0463% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | -.--% | +16.35% | -6.13% | 1.7TCr | |
| +1.32% | +2.91% | +21.67% | +0.26% | 19TCr | |
| +4.98% | +5.69% | -21.86% | +25.71% | 14TCr | |
| +0.91% | +1.43% | -3.23% | -17.25% | 14TCr | |
| +4.22% | +1.51% | -56.70% | -16.19% | 6.4TCr | |
| +2.11% | +4.72% | +21.99% | +2.69% | 5.3TCr | |
| +1.39% | +1.63% | -26.28% | -31.02% | 4.38TCr | |
| -1.41% | -2.91% | +9.03% | +10.26% | 3.77TCr | |
| -0.66% | -0.67% | +6.37% | +41.39% | 3.71TCr | |
| +0.55% | +0.37% | -14.37% | -19.22% | 2.95TCr | |
| Average | +1.37% | +2.19% | -4.70% | -0.95% | 7.52TCr | |
| Weighted average by Cap. | +1.95% | +3.31% | -3.47% | +0.46% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 403.03Cr 352.17Cr 323.39Cr 301.58Cr 571.72Cr 38TCr 581.37Cr 3.89TCr 1.51TCr 19TCr 1.51TCr 1.48TCr 65TCr | 410.05Cr 358.3Cr 329.02Cr 306.83Cr 581.68Cr 39TCr 591.5Cr 3.96TCr 1.54TCr 19TCr 1.54TCr 1.51TCr 66TCr |
| Net income | 79Cr 69Cr 63Cr 59Cr 112Cr 7.52TCr 113.89Cr 762.74Cr 295.6Cr 3.69TCr 296.44Cr 290Cr 13TCr | 57Cr 49Cr 45Cr 42Cr 80Cr 5.39TCr 82Cr 546.52Cr 211.8Cr 2.64TCr 212.41Cr 207.79Cr 9.1TCr |
| Net Debt | 32Cr 28Cr 26Cr 24Cr 46Cr 3.06TCr 46Cr 310.41Cr 120.3Cr 1.5TCr 120.64Cr 118.02Cr 5.17TCr | 42Cr 37Cr 34Cr 31Cr 60Cr 4.01TCr 61Cr 406.63Cr 157.59Cr 1.97TCr 158.04Cr 154.6Cr 6.77TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions
